Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    NP001
Show Display Options
Rank Status Study
1 Completed Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
2 Completed A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
3 Recruiting Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
4 Recruiting Minimally Invasive Treatment of Worn Dentition With Innovative CAD-CAM Composites
Condition: Tooth Wear
Intervention: Device: "No prep" treatment of worn dentition with CAD-CAM composite
5 Completed Comparison of Three Tourniquet Application Methods in Primary Total Knee Arthroplasty Surgery
Condition: Knee Osteoarthritis
Intervention: Procedure: Total knee arthroplasty performed under tourniquet

Indicates status has not been verified in more than two years